phrykt

Supernus, Inc. (SUPN): who owns it and who trades it

As of Nov 3, 2026, SUPN insiders reported 3 open-market sales worth $2.8M and 7 purchases worth $229K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christian Heidbreder (Chief Scientific Officer), with $1.5M.

Latest filing Nov 3, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, SUPN insiders reported $229K of open-market purchases and $2.8M of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$229K
7 trades, 4 people
Sales, 12 months
$2.8M
3 trades, 2 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
Aug 27, 2026
Filed Aug 27, 2026

Purchases and sales by month

$2.1M$2.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 27, 2026Woodrow D AndersonChief Accounting OfficerPurchase1,500$35.69$53.5KForm 4
Aug 5, 2026Woodrow D AndersonChief Accounting OfficerPurchase1,500$36.28$54.4KForm 4
Jul 10, 2026Christian HeidbrederChief Scientific OfficerSale plan18,586$41.14$765KForm 4
Jun 11, 2026Christian HeidbrederChief Scientific OfficerSale plan18,586$38.06$707KForm 4
Jun 8, 2026Ryan PreblickCFOSale plan36,000$37.70$1.4MForm 4
Mar 13, 2026Barbara RyanDirectorPurchase8$31.09$249Form 4
Mar 9, 2026Barbara RyanDirectorPurchase31$32.56$1KForm 4
Mar 6, 2026Stuart A KingsleyDirectorPurchase940$31.87$30KForm 4
Jan 5, 2026Barbara RyanDirectorPurchase plan775$35.39$27.4KForm 4
Jan 5, 2026David E. WheadonDirectorPurchase plan1,771$35.39$62.7KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Christian HeidbrederChief Scientific Officer–$1.5MJul 10, 2026
Ryan PreblickChief Financial Officer–$1.4MJun 8, 2026
Woodrow D AndersonChief Accounting Officer$108K–Aug 27, 2026
David E. WheadonDirector$62.7K–Jan 5, 2026
Stuart A KingsleyDirector$30K–Mar 6, 2026
Barbara RyanDirector$28.7K–Mar 13, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SUPN short interest

Low short interest. 3.9% of SUPN shares are sold short: about 1 share in 26. Over the last 12 reports the number of shares short went down 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.62M SUPN shares were sold short, 3.9% of the shares outstanding, up 14.2% from the report before. At the average daily volume of 1.35M shares, buying them all back would take about 3.4 trading days (days to cover).

Shares short, % of all shares

3.91%May 15Oct 306.22%

Days to cover

3.4May 15Oct 3011.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.62M3.91%+14%1.35M3.4
Oct 15, 20264.04M3.43%-19%819,8794.9
Sep 30, 20264.99M4.22%-0%675,9997.4
Sep 15, 20264.99M4.23%+7%576,5258.7
Aug 31, 20264.67M3.96%+13%565,4438.3
Aug 14, 20264.15M3.51%-14%1.48M2.8
Jul 31, 20264.82M4.08%-1%506,4789.5
Jul 15, 20264.85M3.98%-32%947,8185.1
Jun 30, 20267.14M5.86%+17%1.03M7.0
Jun 15, 20266.10M5.01%+13%602,83610.1
May 29, 20265.42M4.44%+15%570,4359.5
May 15, 20264.73M3.88%+0%894,3965.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded SUPN

Since Nov 17, 2024, 1 member of Congress reported 3 purchases and 1 sale of SUPN. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Mar 3, 2026, reported Apr 7, 2026.

Purchases 3Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Mar 3, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfApr 7, 2026Report
Dec 11, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJan 12, 2026Report
Oct 9, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfNov 18, 2025Report
Mar 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfApr 7, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Supernus company events

Supernus filed 23 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, control). The latest was on Nov 3, 2026.

  1. Nov 3, 2026AnnouncementMade another announcement. Filing
  2. Nov 2, 2026LeadershipDeparture of Officers Consistent with the terms of the Merger Agreement, effective as of the Effective Time, Joseph Ciaffoni ceased to serve as Chief Executive Officer of Indivior, Ryan Preblick ceased to serve as Chief Financial Officer of Indivior, Patrick Barry ceased to serve as Chief… Filing
  3. Oct 29, 2026ResultsReleased financial results. Filing
  4. Oct 15, 2026VoteReported shareholder vote results. Filing
  5. Oct 6, 2026AnnouncementAs previously reported, on August 1, 2026, Indivior Pharmaceuticals, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., a Delaware corporation and Artemis Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Indivior. Filing
  6. Sep 17, 2026AnnouncementOf this Current Report on Form 8-K). Filing
  7. Sep 15, 2026AgreementEnded an important agreement. Filing
  8. Aug 3, 2026AnnouncementShared information with investors. Filing
  9. Aug 3, 2026ResultsReleased financial results. Filing
  10. Aug 3, 2026AgreementIndivior Pharmaceuticals, Inc., a Delaware corporation and Artemis Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Indivior, entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., a Delaware corporation. Filing
  11. May 15, 2026LeadershipIndivior Pharmaceuticals, Inc. will eliminate the position of Chief Scientific Officer. Filing
  12. May 4, 2026AnnouncementShared information with investors. Filing
  13. Apr 30, 2026ResultsReleased financial results. Filing
  14. Mar 17, 2026AgreementIndivior Pharmaceuticals, Inc. issued $500 million principal amount of its 0.625% Convertible Senior Notes due 2031. Filing
  15. Mar 13, 2026AnnouncementThe Company announced the pricing of its offering of 0.625% convertible senior notes due 2031. Filing
  16. Mar 12, 2026AnnouncementThe Company announced the launch of its proposed offering of convertible senior notes due 2031. Filing
  17. Feb 26, 2026ResultsReleased financial results. Filing
  18. Jan 26, 2026ControlThe information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this Item 5.01. Filing
  19. Jan 8, 2026AnnouncementShared information with investors. Filing
  20. Dec 22, 2025AnnouncementShared information with investors. Filing
  21. Dec 18, 2025LeadershipThe Board of Directors of Indivior PLC approved the following base salary changes for the Company's executive officers, effective January 1, 2026, based on a review of the competitive market and the recommendations of the Compensation Committee and the Board's compensation consultant: Joseph… Filing
  22. Dec 15, 2025VoteReported shareholder vote results. Filing
  23. Nov 20, 2025AgreementEnded an important agreement. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Supernus financials

Questions about Supernus, Inc. (SUPN) stock

Are SUPN insiders buying or selling?

In the last 12 months, SUPN insiders reported 7 open-market purchases worth $229K and 3 sales worth $2.8M. The latest trade was on Aug 27, 2026. See every trade.

What is the short interest in SUPN?

As of Oct 30, 2026, 4.62M SUPN shares were sold short, 3.9% of the shares outstanding, up 14.2% from the report before. At the average daily volume of 1.35M shares, buying them all back would take about 3.4 trading days (days to cover). See the history.

Have members of Congress traded SUPN?

Yes. 1 member of Congress reported 3 purchases and 1 sale of SUPN since Nov 17, 2024. The latest was reported on Apr 7, 2026. See the trades.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.